Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 270 entries
View as:

Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02277574 Org: User:
Start: 06/30/14 End: 07/31/15 Due: 07/31/16

Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02350751 Org: User:
Start: 01/31/15 End: 06/30/15 Due: 06/30/16

A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas

Phase: N/A Priority: Normal
NCT ID: NCT01284231 Org: User:
Start: 12/31/10 End: 01/31/15 Due: 01/31/16

A Double-blind, Placebo-controlled, Single-dose Study to Evaluate the PK, IM, and Safety in Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02213315 Org: User:
Start: 07/31/14 End: 12/31/14 Due: 12/31/15

Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT00299819 Org: User:
Start: 03/31/06 End: 10/31/07 Due: 10/31/08

A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02512900 Org: User:
Start: 09/10/15 End: 05/17/16 Due: 05/17/17

A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00508651 Org: User:
Start: 10/31/07 End: 04/30/09 Due: 04/30/10

A Pilot Study Investigating Bioequivalence Between a Single Dose of Formulation 2 and Formulation 3 of MEDI0382

Phase: N/A Priority: Normal
NCT ID: NCT03341013 Org: User:
Start: 11/30/17 End: 01/29/18 Due: 01/29/19

A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness

Phase: N/A Priority: Normal
NCT ID: NCT00435227 Org: User:
Start: 03/20/07 End: 05/31/08 Due: 05/31/09

A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01322594 Org: User:
Start: 03/31/11 End: 12/31/11 Due: 12/31/12

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

Phase: N/A Priority: Normal
NCT ID: NCT00192478 Org: User:
Start: 02/29/04 End: 08/31/06 Due: 08/31/07

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03489525 Org: User:
Start: 05/08/18 End: 03/21/22 Due: 03/21/23

MEDI-557 Adult Dosing

Phase: N/A Priority: Normal
NCT ID: NCT01562938 Org: User:
Start: 03/31/12 End: 07/31/13 Due: 07/31/14

A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses

Phase: N/A Priority: Normal
NCT ID: NCT03362593 Org: User:
Start: 12/04/17 End: 05/11/20 Due: 05/11/21

A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03625778 Org: User:
Start: 08/14/18 End: 08/25/19 Due: 08/25/20

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02054130 Org: User:
Start: 12/13/13 End: 03/01/17 Due: 03/01/18

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

Phase: N/A Priority: Normal
NCT ID: NCT00192413 Org: User:
Start: 03/31/02 End: 11/30/02 Due: 11/30/03

A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus

Phase: N/A Priority: Normal
NCT ID: NCT00657189 Org: User:
Start: 07/31/08 End: 05/31/10 Due: 05/31/11

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03106428 Org: User:
Start: 03/29/17 End: 01/03/20 Due: 01/03/21

Safety and Tolerability of MEDI3506 in Healthy Participants, in Participants With COPD and Healthy Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03096795 Org: User:
Start: 05/15/17 End: 09/30/19 Due: 09/30/20

A Study to Assess the Safety and Immunogenicity of the Drug CAT-354 in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01093040 Org: User:
Start: 04/30/10 End: 10/31/10 Due: 10/31/11

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT00587015 Org: User:
Start: 08/31/07 End: 10/31/09 Due: 10/31/10

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01334853 Org: User:
Start: 01/31/11 End: 09/30/12 Due: 09/30/13

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01997450 Org: User:
Start: 12/02/13 End: 04/15/16 Due: 04/15/17

A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction

Phase: N/A Priority: Normal
NCT ID: NCT03578809 Org: User:
Start: 06/05/18 End: 01/18/21 Due: 01/18/22